Key result
Pediatric cardiac devices and prostheses account for ~10% of all infective endocarditis cases.
Why the study?
To provide a comprehensive review of infective endocarditis associated with cardiac devices and prostheses in pediatric patients, including recent advances in diagnosis and management.
Population
Pediatric patients with cardiac devices and prostheses
Design
Comprehensive review
Authors
Loading...
Intensified IE prevention warranted in cyanotic congenital heart disease; reinforces guideline risk stratification for high-risk cardiac patients.
This review summarizes recent advances in the diagnosis and management of infective endocarditis associated with cardiac devices and prostheses in the pediatric population.
Dardari et al. (2023) conducted a review in Infective endocarditis. Cardiac devices and prostheses was evaluated. Cardiac devices and prostheses in pediatric patients carry significant infective endocarditis risks, representing 10% of all endocarditis cases and up to 1.6% for Melody valve implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: